undamentalytics Newsletter
Sign in

Sera Prognostics, Inc. income statement

In fiscal 2025, Sera Prognostics, Inc. reported revenue of $81,000, up 5.2% on the year before, operating income of −$36.5m (a -45066.7% margin) and net income of −$31.9m, or −$0.67 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue0000000
Cost of revenue———0000
Gross profit———0−0−0−0
Research and development8111415151313
Selling and marketing410158678
General and administrative7141716161717
Operating income−18−35−46−40−37−37−37
Interest expense———0000
Income before tax————−33−32—
Income tax000000—
Net income−20−35−44−36−33−32−33
Diluted EPS−$0.64−$1.17−$1.43−$1.16−$0.99−$0.67−$0.66
Diluted shares (average)31m30m31m31m33m48m50m
EBITDA−17−35−45−39−36−36−36

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ACON vs SERAISPC vs SERASERA vs YDES

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Sera Prognostics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Sera Prognostics, Inc.